Inventor · disambiguated record
Andrew Scholte
Also filed as: SCHOLTE ANDREW
12 granted patents·3 pending applications·76 citations·filing 2014–2025
91Inventor score
Top patents by PatentIndex Score
15 records- 0196US11878024B2Tropomyosin-related kinase (Trk) inhibitorsGENZYME CORP·Filed 2022·Granted Jan 23, 2024·3 cites·6 claims
- 0296US11406644B2Tropomyosin-related kinase (TRK) inhibitorsGENZYME CORP·Filed 2020·Granted Aug 9, 2022·5 cites·21 claims
- 0394US12318392B2Tropomyosin-related kinase (trk) inhibitorsGENZYME CORP·Filed 2023·Granted Jun 3, 2025·1 cites·27 claims
- 0494US9174986B2Tropomyosin-related kinase (Trk) inhibitorsGENZYME CORP·Filed 2015·Granted Nov 3, 2015·13 cites·1 claims
- 0593US9067914B1Tropomyosin-related kinase (TRK) inhibitorsGENZYME CORP·Filed 2014·Granted Jun 30, 2015·15 cites·1 claims
- 0692US10166239B2Tropomyosin-related kinase (Trk) inhibitorsGENZYME CORP·Filed 2017·Granted Jan 1, 2019·9 cites·33 claims
- 0792US9611265B2Tropomyosin-related kinase (TRK) inhibitorsGENZYME CORP·Filed 2015·Granted Apr 4, 2017·11 cites·10 claims
- 0888US9663524B2Substituted pyrido[2,3-d]pyrimidines as protein kinase inhibitorsCELGENE CAR LLC·Filed 2014·Granted May 30, 2017·15 cites·27 claims
- 0985US2025288595A1Tropomyosin-related kinase (trk) inhibitorsGENZYME CORP·Filed 2025·Application pending·0 cites
- 1084US11274108B2Colony stimulating factor-1 receptor (CSF-1R) inhibitorsGENZYME CORP·Filed 2016·Granted Mar 15, 2022·2 cites·15 claims
- 1179US12503477B2Colony stimulating factor-1 receptor (CSF-1R) inhibitorsGENZYME CORP·Filed 2024·Granted Dec 23, 2025·0 cites·6 claims
- 1277US10065966B2Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinasesCELGENE CAR LLC·Filed 2017·Granted Sep 4, 2018·2 cites·27 claims
- 1369US2022396588A1Colony stimulating factor-1 receptor (csf-1r) inhibitorsGENZYME CORP·Filed 2022·Application pending·0 cites
- 1468US2019183903A1Tropomyosin-related kinase (trk) inhibitorsGENZYME CORP·Filed 2018·Application pending·0 cites
- 1562US10618902B2Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinasesCELGENE CAR LLC·Filed 2018·Granted Apr 14, 2020·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Andrew Scholte files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →